The Unmet Need for Intrathecal Drug Delivery Pumps for the Treatment of Cancer Pain in England: An Assessment of the Hospital Episode Statistics Database
ConclusionsWe observed a substantial gap between the need and provision of ITDD for patients with refractory cancer pain in England despite the recommendation for the use of ITDD for this patient population. In addition, we present suggestions for improvement of access to and provision of ITDD in England.
Source: Neuromodulation: Technology at the Neural Interface - Category: Biotechnology Authors: Rui V. Duarte,
Alicia Sale,
Pallav Desai,
Theresa Marshall,
Sam Eldabe Tags: Clinical Research Source Type: research
More News: Biotechnology | Brain | Cancer | Cancer & Oncology | Databases & Libraries | Neurology | Pain | Pain Management | Statistics | Study